Skip to content
Thursday, August 13, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • Judge throws out Trump’s Harvard antisemitism lawsuit, citing lack of evidence August 13, 2026
  • Evolution is the Goal of Textual Study August 13, 2026
  • ‘History cannot be erased’: ‘Hostages Square’ in Tel Aviv is formalized in official name change August 13, 2026
  • New Initiative Says ‘Enough’ to the Boycott of Israeli Academics August 12, 2026
  • Iran appoints AMIA bombing suspect to National Security Council August 11, 2026
  • Choosing Truth Over Tribe in Alyssa Rosenheck’s “White. Blonde. Jew.” August 11, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.